Rashmi Goswami, MD, PhD, FRCPC, DABP, FCAP, obtained her undergraduate degrees in genetics and medical microbiology from the University of Manitoba and her medical degree from the University of Toronto. She completed her residency in anatomical pathology at McGill University and returned to the University of Toronto to complete her PhD on the use of microRNAs as prognostic biomarkers in lymphoma. Dr. Goswami received clinical subspecialty training in hematopathology and molecular genetic pathology at the Vancouver General Hospital/British Columbia Cancer Agency and the MD Anderson Cancer Center. She holds U.S. board certification in both hematopathology and molecular genetic pathology.
Dr. Goswami is a member of the Association of Molecular Pathology (AMP), where she is the hematopathology representative on the AMP Clinical Practice Committee and serves on the AMP Molecular MRD Monitoring in Acute Myeloid Leukemia Working Group. This group is working to provide a comprehensive assessment of the clinical utility of molecular biomarkers in AML MRD monitoring in order to review available molecular test platforms and workflow considerations for clinical testing.
Dr. Goswami is an Assistant Professor in the
Department of Laboratory Medicine and Pathobiology at the University of Toronto.